Support vector machines coupled with proteomics approaches for detecting biomarkers predicting chemotherapy resistance in small cell lung cancer

Author：                

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.28, Iss.6, 2012-01, pp. : 2233-2238

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic implications of survivin and lung resistance protein in advanced non-small cell lung cancer treated with platinum-based chemotherapy

By                      

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 723-730

Spandidos Publications

Access to resources Recommend Favorite

Optimizing Chemotherapy in Non-Small Cell Lung Cancer

By Rosell Rafael  

American Journal of Cancer, Vol. 5, Iss. 4, 2006-01 ,pp. : 211-212

Adis International

Access to resources Recommend Favorite

Adjuvant Chemotherapy for Non-Small Cell Lung Cancer

By Solomon Benjamin   Bunn Paul A.  

Cancer Investigation, Vol. 25, Iss. 4, 2007-06 ,pp. : 217-225

Informa Healthcare

Access to resources Recommend Favorite

Adding a Reverser (Verapamil) to Combined Chemotherapy Overrides Resistance in Small Cell Lung Cancer Xenografts

By Arvelo F.   Bichat F.   Grossin F.   Bourgeois Y.   Jacrot M.   Bastian G.   Poupon M.F.   Le Chevalier T.  

European Journal of Cancer, Vol. 31, Iss. 11, 1995-10 ,pp. : 1862-1868

Elsevier

Access to resources Recommend Favorite

Role of BCL2-associated athanogene in resistance to platinum-based chemotherapy in non-small-cell lung cancer

By            

Oncology Letters, Vol. 11, Iss. 2, 2016-01 ,pp. : 984-990

Spandidos Publications

Access to resources Recommend Favorite